During the past decade, Instituto Oncologico De Cordoba conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Oncologico De Cordoba" #1 collaborator was "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator, "Eurofarma Laboratorios S.A." with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator and "Laboratorio Elea Phoenix S.A." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Oncologico De Cordoba" are "Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma" (1 trials), "Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Lung Cancer, Non-small Cell" (1 trials). Many other conditions were trialed in "Instituto Oncologico De Cordoba" in a lesser frequency.

Most popular intervention types in "Instituto Oncologico De Cordoba" are "Drug" (7 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (3 trials), "BCG" (1 trials), "BMS-936558 (Nivolumab)" (1 trials), "BMS-986205" (1 trials) and "Best Support Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oncologico De Cordoba" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Oncologico De Cordoba". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Instituto Oncologico De Cordoba, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oncologico De Cordoba, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".